According to Coherent Market Insights, the global single-cell omics market size is estimated to be valued at USD 1.63 billion in 2023 and is expected to surpass USD 4.62 billion by 2030, growing at a CAGR of 16% from 2023 to 2030.
The growth of the
global single cell Omics market is primarily driven by the increasing
application of single cell analysis in cancer research. Single cell analysis
helps understand tumor diversity at single cell resolution. It also helps
identify rare cell subpopulations. Moreover, the increasing demand for
personalized medicine is also influencing the market growth. Single-cell omics
approaches are being applied to develop more patient-tailored treatments. Request a
Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/6571
Market Trends Implementation of
single-cell and multi-omics workflows: Implementation of integrated single-cell
and multi-omics techniques are gaining significant traction. These techniques
analyze multiple biological parameters such as DNA, RNA, proteins, metabolites,
etc. from a single cell. These multi-dimensional analyses provide a comprehensive
view of cellular behavior and cellular heterogeneity. Key players are
focused on developing robust microfluidic lab-on-a-chip platforms for
high-throughput single-cell analysis. These platforms facilitate automated
isolation, lysis and analysis of thousands of single cells in parallel,
allowing comprehensive molecular profiling at an unprecedented scale. Global
Single-cell Omics Market Report Coverage Report Coverage Details Market Revenue in 2023 $1.63 billion Estimated Value by 2031 $4.62 billion Growth Rate Poised to grow at a CAGR of 16% Historical Data 2018–2021 Forecast Period 2023–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape,
Growth Factors, and Trends Segments Covered By Technology, By
Product, By Application, By End User Geographies Covered North America, Europe, Asia Pacific, and
Rest of World Growth Drivers • Growing application areas • Increasing R&D funding Restraints & Challenges • Technical challenges Market
Opportunities Global genomics
segment accounted for the largest market share of over 30% in 2023. Advances in
single-cell genomics techniques such as single-nucleus sequencing is driving
the growth of this market. These techniques allow understanding of complex cell
types and states with unprecedented resolution. Additionally, combining genomic
data with other omics methods such as transcriptomics will help to understand
complex cell types. It helps increase understanding of cell diversity and
increasing use in disease profiling and functional medicine will further
support the genomics segment during the forecast period. Immediate
Delivery Available | Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/6571
The oncology
segment held a share of over 25% in the single-cell omics market in 2023 owing
to increasing focus on cancer immunotherapy and heterogeneity. Single-cell
analysis finds wide usage in cancer subtyping, minimal residual disease detection,
neoantigen prediction and more. It helps characterize intratumoral
heterogeneity and evolution to develop effective treatment strategies. Growing
clinical trials on specific cancer biomarkers identified using single-cell
profiling will boost the oncology segment. Key Market
Takeaways: The global
single-cell omics market is anticipated to witness a CAGR of 16% during the
forecast period 2023-2030, owing to continuous technological advancements in
the field. On the basis of
product type, the genomics segment is expected to hold a dominant position,
accounting for over 30% share due to advances in single-nucleus sequencing. By application,
the oncology segment is expected to hold a dominant position over the forecast
period, owing to increasing focus on cancer immunotherapy and heterogeneity. On the basis of
end-user, pharma & biotech companies segment will dominate the market
driven by increasing R&D investment in Precision Medicine. Regionally, North
America is expected to hold a dominant position over the forecast period,
accounting for over 40% share due to presence of key players and availability
of funding for research. Competitor
Insights - CELLENION - PerkinElmer
Inc. - 10x Genomics - Fluidigm
Corporation - Takara Bio - QIAGEN N.V. Strategic
collaborations and new product launches are the key strategies adopted by these
players. Recent
Developments in single-cell omics market: New Techniques
for Spatial Analysis: Spatial omics has progressed, allowing researchers to map
cellular interactions within tissues with high resolution. For example,
research in 2024 has leveraged spatial transcriptomics to study cell-cell
interactions within tumor microenvironments, crucial for advancing cancer
immunotherapy strategies. Symposiums and
Research Initiatives: Events like the GCC Single Cell Omics Symposium, held in
October 2024, highlight the importance of collaboration and knowledge sharing
in this field. These gatherings allow researchers to exchange insights on new
methodologies and computational tools that enhance data interpretation in
single-cell omics. Ask For
Customization @ https://www.coherentmarketinsights.com/insight/request-customization/6571
Find Most Trending Related Reports: The synthetic
biology market is estimated to be valued at USD 17.88 Bn in 2024 and is
expected to reach USD 73.08 Bn by 2031, growing at a compound annual growth
rate (CAGR) of 22.3% from 2024 to 2031. Global DNA
sequencing market is estimated to be valued at US$ 6,802.2 million in 2023
and is expected to exhibit a CAGR of 11.7% during the forecast period
(2023-2030). Global long
read sequencing market size is expected to reach US$ 5,142.3 Mn by 2031,
from US$ 780 Mn in 2024, exhibiting a compound annual growth rate (CAGR) of
30.9% during the forecast period. Global immunology
market is estimated to be valued at USD 96.51 Bn in 2024 and is expected to
reach USD 216.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of
12.2% from 2024 to 2031. About Us: Coherent Market Insights is a global market intelligence and
consulting organization that provides syndicated research reports, customized
research reports, and consulting services. We are known for our actionable
insights and authentic reports in various domains including aerospace and
defense, agriculture, food and beverages, automotive, chemicals and materials,
and virtually all domains and an exhaustive list of sub-domains under the sun.
We create value for clients through our highly reliable and accurate reports.
We are also committed in playing a leading role in offering insights in various
sectors post-COVID-19 and continue to deliver measurable, sustainable results
for our clients.
Contact Us: Mr. Shah Phone: US: +1-650-918-5898 UK: +44-020-8133-4027 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com 
Senior Client Partner – Business Development
Coherent Market Insights
